Skip to main content
Log in

US Medicaid Drug Formularies

Do they Work?

  • Medicaid Drug Formularies
  • Pharmaco Economics
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Does the use of a restricted drug formulary achieve cost savings within state Medicaid programmes? Restricted formularies are often justified by putting forth the attributes of a perfectly operating and implicitly costless policy. Analysis suggests, however, that the operation of ‘actual’ restricted formularies produce realised effects that are substantially at odds with the desired effects. Although the implementation of a restricted formulary can reduce a state’s drug expenditures, service substitution causes expenditures to increase elsewhere in the system. Furthermore, direct savings in the drug budget are completely offset by these spillover effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Demsetz H. Information and efficiency: another viewpoint. Journal of Law and Economics XII: 1–22, 1966

    Google Scholar 

  • Dranove D. Medicaid drug formulary restrictions. Journal of Law and Economics 33: 143–162, 1989

    Article  Google Scholar 

  • Jang R. Medicaid formularies: a critical review of the literature. Journal of Pharmaceutical Marketing and Management 2 (3): 39–61, 1988

    PubMed  CAS  Google Scholar 

  • Moore WJ, Newman RJ. Drug formulary restrictions as a costcontainment policy in Medicaid programs. Department of Economics Working Paper, Louisiana State University, 1991

    Google Scholar 

  • National Pharmaceutical Council (NPC). Pharmaceutical Benefits UnderState Medical Assistance Programs, September 1990

    Google Scholar 

  • Reeder EC, Lingle EW. An evaluation of the South Carolina Medicaid open formulary system. Final report submitted National Pharmaceutical Council, Inc., Washington, DC, 1988

    Google Scholar 

  • Rucker D, Schit TG. Drug formularies: myths—in—formation. Medical Care 28: 928–939, 1990

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moore, W.J., Newman, R.J. US Medicaid Drug Formularies. Pharmacoeconomics 1 (Suppl 1), 28–31 (1992). https://doi.org/10.2165/00019053-199200011-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199200011-00008

Keywords

Navigation